2347
Susceptibility weighted imaging for quantitatively evaluation of dual‑phenotype hepatocellular carcinoma
Ying Zhao1, Ailian Liu1, Wenjing Qi2, Xue Ren1, Tao Lin1, and Qingwei Song1
1The First Affiliated Hospital of Dalian Medical University, Dalian, China, 2Department of Pathology, The First Affiliated Hospital, Dalian Medical University, Dalian, China
This study showed that R2* of susceptibility weighted imaging (SWI) provided a promising performance (AUC = 0.830, sensitivity = 85.0%, specificity = 77.3%) in quantitatively evaluating dual-phenotype hepatocellular carcinoma (DPHCC).
Table 1. Detailed MR scanning parameters
Figure 3. ROC curve for discrimination of DPHCC and non-DPHCC.